MedTrace Logo

Treatment of the Overactive Bladder Syndrome: A Delphi Study

NCT04300400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-01-19

No results posted yet for this study

Summary

Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even guidelines are not always clear on the treatment management of drug therapy resistant OAB. Standardization in OAB treatment is needed.

Conditions

  • Overactive Bladder Syndrome

Interventions

OTHER

Delphi questionnaire

Statements on OAB topics, rated along their level of appropriateness on a scale from 1 to 9. Multiple rounds are organised to reach consensus on a topic.

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Medtronic

    collaborator INDUSTRY

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Lynn Ghijselings, MD · University Hospital, Ghent

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2019-07-23
Completion
2019-09-10

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04300400 on ClinicalTrials.gov